Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Cell, 2026
Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome

Koprulu M., Smith-Byrne K., Ferolito B. et al.

Olink Target 96Olink Explore 3072/384Wider Proteomics StudiesPathophysiologyPlasma

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2026
Evidence for an energy conservation model of inflammaging and immunosenescence in the US Health and Retirement Study and UK Biobank

Aronoff J., Franck M., Cohen A. et al.

Olink Explore 3072/384AgingPathophysiologyPlasma

Cell Reports, 2026
Cohesin complex cooperates with PU.1 at super-enhancers to regulate the differentiation and identity of conventional dendritic cells

Choubey P., Kumar A., Podder S. et al.

Olink Target 48 MouseImmunological & Inflammatory DiseasesPathophysiologyMouse Serum

American Journal of Preventive Cardiology, 2026
Large-scale plasma proteomics improves prediction of heart failure among MASLD individuals: A prospective cohort study

Xiong Z., Chen S., Huang H. et al.

Olink Explore 3072/384Metabolic DiseasesCVDHepatologyPatient StratificationPlasma

Journal of Extracellular Biology, 2026
The Proteo‐Transcriptome of Extracellular Vesicles and Particles Is Largely Preserved After Cryopreservation

Nose Y., Valle D., Gonsalves T. et al.

Olink Target 96OncologyTechnical StudiesTechnical EvaluationEV Lysate

eBioMedicine, 2026
Multi-omics analysis of the gut microbiome and carotid artery atherosclerosis in men with and without HIV

Wang Z., Wang Y., Peters B. et al.

Olink Explore 3072/384CVDInfectious DiseasesPathophysiologyPlasma

Translational Oncology, 2026
Clinical validation of PEA-driven Olink proteomic discovery: INPP1 and ARHGAP25 serum biomarkers improve early breast cancer diagnosis

Huang J., Gao L., Glazutdinova L. et al.

Olink Explore 3072/384OncologyPatient StratificationSerum

Journal of Clinical & Translational Endocrinology, 2026
Increased cytokine production capacity and persistent inflammation after achieving remission of Cushing’s syndrome

van Houten P., van de Ven A., van Herwaarden A. et al.

Olink Target 96EndocrinologyPathophysiologyPlasma

npj Digital Medicine, 2026
Leveraging population-scale proteomic data with deep learning for head and neck cancer detection in saliva

Shakeel A., Merriel S., Smith J. et al.

Olink Target 96Olink Explore 3072/384OncologyWider Bioinformatics StudiesTechnical EvaluationData SciencePlasmaSaliva

ERJ Open Research, 2026
Proteome-wide Mendelian randomisation of lung function to identify potential therapeutic targets for respiratory disease

Chen J., Shrine N., Coley K. et al.

Olink Explore 3072/384Respiratory DiseasesPathophysiologyPlasma

Blood Cancer Journal, 2026
A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients

Firestone R., Simhal A., Akhlaghi T. et al.

Olink Target 96OncologyPatient StratificationPlasma

Atherosclerosis, 2026
Inflammation may explain part of atherosclerotic cardiovascular disease risk conferred by elevated remnant lipoproteins: a cohort and Mendelian randomization study

Wadström B., Wulff A., Pedersen K. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

JHEP Reports, 2026
Hepatic flares, their immune signatures, and ALT variability after nucleos(t)ide analogue cessation in HBeAg-negative hepatitis B

Holmberg M., Niehrs A., Dalgard O. et al.

Olink Target 96HepatologyPathophysiologySerum

eBioMedicine, 2026
A randomized, observer-blind, phase 1 study of immune responses to three human adenovirus type 26 vector–based vaccines

Hertoghs N., Serroyen J., Tolboom J. et al.

Olink Explore 3072/384Olink Target 48Immunological & Inflammatory DiseasesPathophysiologyPlasma

Archives of Medical Science, 2026
Deciphering the Interplay Between Inflammatory Factors and Brain Structural Features in Epilepsy

Fang S., Dong X., Li X. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Neurobiology of Disease, 2026
Machine learning based multi-omics analysis reveals key molecular determinants of Parkinson's disease severity

Jin H., Meng L., Yulug B. et al.

Olink Explore 3072/384NeurologyPatient StratificationPlasma

Neurobiology of Disease, 2026
A NETs-centric multi-omics framework prioritizes PGLYRP1 and MMP9 as subtype-associated thromboinflammatory biomarker candidates and putative therapeutic hypotheses in ischemic stroke

Tan H., Gong H., Li H. et al.

Olink Target 96CVDNeurologyPathophysiologyPlasma

Lung Cancer, 2026
A dynamic proteomic signature for the prediction of lung Cancer: a longitudinal analysis in the UK Biobank cohort

Liang J., Feng Y., Gui D. et al.

Olink Explore 3072/384OncologyPathophysiologyPatient StratificationPlasma

Journal of Infection, 2026
Early antiretroviral therapy shapes the immunometabolic landscape without reducing the intact HIV reservoir

Suanzes P., Grau-Expósito J., Navarro J. et al.

Olink Target 48Infectious DiseasesPathophysiologyPlasma

Nature Biotechnology, 2026
mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression

Marks A., Siu S., Bianchini F. et al.

Olink Target 96 MouseImmunological & Inflammatory DiseasesPathophysiologyMouse Cell Culture Supernatant

4098 publications